Methods of treating impaired glucose metabolism via administration of algal biomass
US9345730B2 · kind B2 · utility
4Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 30, 2014 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Jul 11, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to methods of using Chlorella protothecoides microalgal biomass in the treatment of individuals having impaired glucose metabolism. In some cases, the patient has impaired fasting glucose, impaired glucose tolerance, or diabetes. In some methods, algal biomass is used to reduce blood glucose and/or body fat in a subject, or to increase the relative abundance of beneficial gut microflora in a subject. In preferred embodiments, the biomass is derived from Chlorella protothecoides cultures grown heterotrophically in which the algal cells comprise at least 15% algal oil by dry weight.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.